𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bleomycin combination chemotherapy in the management of testicular neoplasia

✍ Scribed by Melvin L. Samuels; Paul Y. Holoye; Douglas E. Johnson

Publisher
John Wiley and Sons
Year
1975
Tongue
English
Weight
749 KB
Volume
36
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Early resection of residual tumor during
Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer
✍ Giorgio Pizzocaro; Roberto Salvioni; Massimo Pasi; Fulvio Zanoni; Angelo Milani; πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 630 KB

Sixty consecutive patients with Stage I11 or bulky Stage II nonseminatous germinal testis tumors were treated with cisplatin, vinblastine, bleomycin combination chemotherapy (PVB). One patient died of acute toxicity after the first course of therapy, 16 entered complete remission (CR) after two or t

Combined chemotherapy and local treatmen
Combined chemotherapy and local treatment in the management of intraocular retinoblastoma
✍ Brichard, BοΏ½nοΏ½dicte ;De Bruycker, Jean Jacques ;De Potter, Patrick ;Neven, BοΏ½nοΏ½d πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 68 KB

## Abstract ## Background To assess the efficacy of chemotherapy (chemoreduction) plus local treatments as an alternative to external beam and enucleation for intraocular retinoblastoma. ## Materials and Methods A prospective study was performed on 21 patients with retinoblastoma treated in our

Controversies in the management of testi
Controversies in the management of testicular seminoma
✍ Dr. Gillian M. Thomas πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 702 KB

The 5-year cause specific actuarial survival rate for 178 patients treated for testicular seminoma at The Princess Margaret Hospital 1977 to 1981 is 97%. Controversies exist over how to optimally use and integrate chemotherapy (a) and radiation therapy ( R I ) to minimize morbidity and achieve these

Use of 111in-bleomycin for combining rad
Use of 111in-bleomycin for combining radiotherapy and chemotherapy on glioma-bearing mice
✍ De-Yan Hou; Hans Hoch; Gerald S. Johnston; K. C. Tsou; Raymond J. Farkas; Elizab πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 624 KB

Mice bearing transplanted glioma received 0.9% NaCl, 0.1 mg of BLM, or 200-250 pCi of "'In-BLM (0.1 mg BLM) daily for 5 days intraperitoneally. After therapy, tumor sizes were in the order NaCl > BLM > "'In-BLM. On the 11th day after the first injection, tumor size (m3) in the "'In-BLM group was 1,2